Compare ETON & KREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETON | KREF |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.7M | 399.8M |
| IPO Year | 2018 | N/A |
| Metric | ETON | KREF |
|---|---|---|
| Price | $26.96 | $6.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $39.33 | $9.58 |
| AVG Volume (30 Days) | 465.8K | ★ 1.3M |
| Earning Date | 05-12-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 15.18% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $79,950,000.00 | N/A |
| Revenue This Year | $40.90 | $545.92 |
| Revenue Next Year | $47.23 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $13.09 | $5.87 |
| 52 Week High | $27.19 | $9.98 |
| Indicator | ETON | KREF |
|---|---|---|
| Relative Strength Index (RSI) | 72.35 | 56.40 |
| Support Level | $16.23 | $6.64 |
| Resistance Level | N/A | $7.50 |
| Average True Range (ATR) | 1.19 | 0.19 |
| MACD | 0.07 | 0.09 |
| Stochastic Oscillator | 94.39 | 99.40 |
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.